Skip to main content

Substance Use Disorder Treatment in Primary Care: An Emerging Model

Symposium Webinar
Friday, October 16, 2020 - 12:00 pm - 1:15 pm EDT

This webinar has already occurred. The recorded webinar is now available.

Several innovative programs have emerged to combat the opioid epidemic in our different regions. One program under development in Monroe County and surrounding counties in Western New York State is the Substance Use Disorders in Primary Care (SUD-PC) Initiative. Leaders of this initiative will present about its coordinated response to the opioid epidemic: the development of a mobile team to provide triage and rapid treatment initiation, a central hub to provide support to primary care and emergency department providers, and deployable resources to expand treatment reach while minimizing the need for additional space.

About the Symposium:

The theme of this year’s Department of Psychiatry Collaborative Care and Wellness Division Annual Symposium on Behavioral Health Integration is Treatment on Demand and the Ecosystem of Recovery: Helping Patients and Communities Recover from the Opioid Crisis. Throughout the month of October, presenters will discuss strategies for addressing the opioid epidemic with a focus on rural communities.

Presenters

Image
Patrick Seche
Patrick Seche, M.S., CASAC

Patrick Seche is the Senior Director of Addiction Services and a Senior Associate faculty member in the University of Rochester Medical Center’s Department of Psychiatry, and currently oversees three clinics at Strong Recovery, which is a part of Strong Memorial Hospital. On the steering committee for the University of Rochester’s Recovery Center of Excellence, Patrick focuses on substance use disorder, methadone treatment, and community relations.

Image
Photo of Jared Walsh
Jared P. Walsh, MD

Dr. Walsh attended college at Boston College in Chestnut Hill, MA where he earned a degree in Psychology with a focus in Biopsychology through the Psychology Honors Program. After graduation, he worked at the Massachusetts General Hospital where he was a clinical research coordinator for multi-center pharmacogenetic clinical trials. Afterwards, he attended Boston University School of Medicine where he earned his medical degree and a master of arts degree.